Literature DB >> 8521461

Yes, but do they still get headaches?

D DeWitt1, W L Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8521461     DOI: 10.1016/0092-8674(95)90109-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


× No keyword cloud information.
  19 in total

1.  Phenotypic and functional characterisation of myofibroblasts, macrophages, and lymphocytes migrating out of the human gastric lamina propria following the loss of epithelial cells.

Authors:  K C Wu; L M Jackson; A M Galvin; T Gray; C J Hawkey; Y R Mahida
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

2.  Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus.

Authors:  D Pyeon; F J Diaz; G A Splitter
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets.

Authors:  K E Bornfeldt; J S Campbell; H Koyama; G M Argast; C C Leslie; E W Raines; E G Krebs; R Ross
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

4.  Lysophosphatidylcholine acyltransferase activity in Saccharomyces cerevisiae: regulation by a high-affinity Zn2+ binding site.

Authors:  M G Richard; C R McMaster
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

5.  Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus.

Authors:  S A Litherland; X T Xie; A D Hutson; C Wasserfall; D S Whittaker; J X She; A Hofig; M A Dennis; K Fuller; R Cook; D Schatz; L L Moldawer; M J Clare-Salzler
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

6.  Nitric oxide (NO) modulation of PAF-induced cardiopulmonary action: interaction between NO synthase and cyclo-oxygenase-2 pathways.

Authors:  F Fabi; R Calabrese; T Stati; P del Basso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.

Authors:  Mahbuba Rahman; Krithika Selvarajan; Mohammad R Hasan; Annie P Chan; Chaoyang Jin; Jieun Kim; Simon K Chan; Nhu D Le; Young-Bae Kim; Isabella T Tai
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

8.  Altered monocyte cyclo-oxygenase response in non-obese diabetic mice.

Authors:  H Beyan; L R Buckley; S A Bustin; N Yousaf; P Pozzilli; R D Leslie
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

9.  Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?

Authors:  Sinan Sozen; Serhat Gurocak; Ozlem Erdem; Cenk Acar; Yakup Kordan; Gulen Akyol; Turgut Alkibay
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

10.  Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.

Authors:  Kasem Nithipatikom; Marilyn A Isbell; Paul F Lindholm; Andre Kajdacsy-Balla; Sushma Kaul; William B Campell
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.